2 Topic Commentaries

Musings from The Power List: Dajun Yang

• 

  Dajun Yang, MD, PhD

  Oncology drug development; targeted small-molecule therapeutics

  •

  Ascentage Pharma

  We believe we are differentiated by superior safety and efficacy profiles and our strong protein-protein interaction (PPI) drug discovery platform.

  Source
• 

  Dajun Yang, MD, PhD

  Protein degradation; oncology drug discovery

  •

  Ascentage Pharma

  The emergence of the PROTAC technology represents another breakthrough in the identification of small molecule drugs. The technology has received tremendous interest for its ability to target undruggable proteins,

  Source